Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Mara Goldstein's Stock Ratings
Mizuho Analyst
Mara Goldstein is an analyst at Mizuho. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/16/2025
Updated: Dec 16, 2025
Overall Average Return
15.9%
Smart Score
Overall Average Return Percentile
70th
Number of Ratings
93
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 05/19/2025 | KURA | Buy Now | Kura Oncology | $10.62 | 182.49% | $32 → $30 | Maintains | Outperform | Get Alert | |
| 05/12/2025 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 362.96% | $30 → $10 | Maintains | Outperform | Get Alert | |
| 04/09/2025 | VSTM | Buy Now | Verastem | $9.43 | -15.16% | $9 → $8 | Maintains | Outperform | Get Alert | |
| 12/19/2024 | VSTM | Buy Now | Verastem | $9.43 | -4.56% | $7 → $9 | Maintains | Outperform | Get Alert | |
| 01/31/2024 | KURA | Buy Now | Kura Oncology | $10.62 | 201.32% | $26 → $32 | Maintains | Buy | Get Alert | |
| 01/30/2024 | RCUS | Buy Now | Arcus Biosciences | $21.91 | 91.69% | $51 → $42 | Maintains | Buy | Get Alert | |
| 01/22/2024 | XNCR | Buy Now | Xencor | $16.79 | 197.8% | $59 → $50 | Maintains | Buy | Get Alert | |
| 12/22/2023 | SNDX | Buy Now | Syndax Pharmaceuticals | $20.82 | 116.12% | → $45 | Initiates | → Buy | Get Alert | |
| 12/22/2023 | KURA | Buy Now | Kura Oncology | $10.62 | 144.82% | → $26 | Initiates | → Buy | Get Alert | |
| 12/14/2023 | INCY | Buy Now | Incyte | $99.08 | -22.29% | $82 → $77 | Maintains | Neutral | Get Alert | |
| 11/29/2023 | ERAS | Buy Now | Erasca | $3.50 | 99.91% | $8 → $7 | Maintains | Buy | Get Alert | |
| 11/20/2023 | FATE | Buy Now | Fate Therapeutics | $1.10 | 627.27% | $12 → $8 | Maintains | Buy | Get Alert | |
| 11/20/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | $20 → $12 | Maintains | Buy | Get Alert | |
| 10/03/2023 | RCUS | Buy Now | Arcus Biosciences | $21.91 | 132.77% | → $51 | Reiterates | Buy → Buy | Get Alert | |
| 09/15/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1288.89% | → $30 | Reiterates | Buy → Buy | Get Alert | |
| 08/29/2023 | VSTM | Buy Now | Verastem | $9.43 | 281.76% | → $36 | Reiterates | Buy → Buy | Get Alert | |
| 08/23/2023 | RCUS | Buy Now | Arcus Biosciences | $21.91 | 132.77% | → $51 | Reiterates | Buy → Buy | Get Alert | |
| 08/07/2023 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -89.8% | → $6 | Reiterates | → Neutral | Get Alert | |
| 06/27/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1288.89% | → $30 | Reiterates | Buy → Buy | Get Alert | |
| 06/16/2023 | CRVS | Buy Now | Corvus Pharma | $8.26 | -57.63% | → $3.5 | Reiterates | Neutral → Neutral | Get Alert | |
| 06/16/2023 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 1288.89% | → $30 | Reiterates | Buy → Buy | Get Alert | |
| 06/15/2023 | VSTM | Buy Now | Verastem | $9.43 | 281.76% | $24 → $36 | Upgrade | Neutral → Buy | Get Alert | |
| 06/06/2023 | ERAS | Buy Now | Erasca | $3.50 | 128.47% | $9 → $8 | Maintains | Buy | Get Alert | |
| 05/09/2023 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $2 → $1.5 | Maintains | Neutral | Get Alert | |
| 05/03/2023 | INCY | Buy Now | Incyte | $99.08 | -17.24% | $95 → $82 | Maintains | Neutral | Get Alert | |
| 04/24/2023 | INAB | Buy Now | IN8bio | $1.60 | 648.5% | → $12 | Reiterates | → Buy | Get Alert | |
| 04/19/2023 | IMRX | Buy Now | Immuneering | $5.83 | 243.05% | $10 → $20 | Upgrade | Neutral → Buy | Get Alert | |
| 04/13/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | → $2 | Reiterates | → Buy | Get Alert | |
| 04/10/2023 | MRK | Buy Now | Merck & Co | $100.50 | 29.35% | → $130 | Reiterates | → Buy | Get Alert | |
| 03/30/2023 | CRVS | Buy Now | Corvus Pharma | $8.26 | -57.63% | → $3.5 | Reiterates | → Neutral | Get Alert | |
| 03/30/2023 | ERAS | Buy Now | Erasca | $3.50 | 157.03% | → $9 | Initiates | → Buy | Get Alert | |
| 03/30/2023 | IMRX | Buy Now | Immuneering | $5.83 | 71.53% | → $10 | Initiates | → Neutral | Get Alert | |
| 03/30/2023 | VSTM | Buy Now | Verastem | $9.43 | -78.79% | → $2 | Initiates | → Neutral | Get Alert | |
| 03/28/2023 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | -51.46% | $4 → $2 | Maintains | Neutral | Get Alert | |
| 03/24/2023 | TCRR | Buy Now | TCR2 Therapeutics | — | — | $20 → $1.72 | Downgrade | Buy → Neutral | Get Alert | |
| 03/17/2023 | MRK | Buy Now | Merck & Co | $100.50 | 29.35% | → $130 | Reiterates | → Buy | Get Alert | |
| 03/17/2023 | RCUS | Buy Now | Arcus Biosciences | $21.91 | 132.77% | → $51 | Reiterates | → Buy | Get Alert | |
| 03/17/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | $3 → $2 | Maintains | Buy | Get Alert | |
| 03/08/2023 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 622.89% | $18 → $12 | Maintains | Buy | Get Alert | |
| 02/10/2023 | XNCR | Buy Now | Xencor | $16.79 | 251.4% | → $59 | Reiterates | → Buy | Get Alert | |
| 02/08/2023 | INCY | Buy Now | Incyte | $99.08 | -4.12% | → $95 | Maintains | Neutral | Get Alert | |
| 01/27/2023 | LPTX | Buy Now | Leap Therapeutics | — | — | $6 → $3 | Maintains | Buy | Get Alert | |
| 11/15/2022 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | $21 → $2 | Downgrade | Buy → Neutral | Get Alert | |
| 11/09/2022 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | → $9 | Upgrade | Neutral → Buy | Get Alert | |
| 07/07/2022 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | -2.91% | $16 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 04/18/2022 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -89.8% | $8 → $6 | Maintains | Neutral | Get Alert | |
| 03/15/2022 | NKTR | Buy Now | Nektar Therapeutics | $58.80 | -86.39% | $35 → $8 | Downgrade | Buy → Neutral | Get Alert | |
| 10/04/2021 | LPTX | Buy Now | Leap Therapeutics | — | — | → $6 | Initiates | → Buy | Get Alert | |
| 10/04/2021 | EFTR | Buy Now | eFFECTOR Therapeutics | $0.00 | 9999900% | → $20 | Initiates | → Buy | Get Alert | |
| 09/14/2021 | KDMN | Buy Now | Kadmon Holdings | — | — | $13 → $9.5 | Downgrade | Buy → Neutral | Get Alert | |
| 08/24/2021 | INAB | Buy Now | IN8bio | $1.60 | 648.5% | → $12 | Initiates | → Buy | Get Alert | |
| 08/03/2021 | CRVS | Buy Now | Corvus Pharma | $8.26 | -57.63% | $4 → $3.5 | Maintains | Neutral | Get Alert | |
| 02/25/2021 | FATE | Buy Now | Fate Therapeutics | $1.10 | 9809.09% | $88 → $109 | Maintains | Buy | Get Alert | |
| 02/10/2021 | CRVS | Buy Now | Corvus Pharma | $8.26 | -51.57% | $7 → $4 | Downgrade | Buy → Neutral | Get Alert | |
| 11/11/2020 | KDMN | Buy Now | Kadmon Holdings | — | — | → $13 | Initiates | → Buy | Get Alert | |
| 06/19/2020 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 1345.78% | $18 → $24 | Maintains | Buy | Get Alert | |
| 06/18/2020 | NLTX | Buy Now | Neoleukin Therapeutics | — | — | → $21 | Initiates | → Buy | Get Alert | |
| 06/01/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $3 → $9 | Maintains | Neutral | Get Alert | |
| 04/22/2020 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | → $3 | Initiates | → Neutral | Get Alert | |
| 04/22/2020 | IOVA | Buy Now | Iovance Biotherapeutics | $2.16 | 2724.07% | → $61 | Initiates | → Buy | Get Alert | |
| 04/22/2020 | AUTL | Buy Now | Autolus Therapeutics | $1.66 | 984.34% | → $18 | Initiates | → Buy | Get Alert | |
| 03/04/2020 | FTSV | Buy Now | Forty Seven | — | — | → $95.5 | Downgrade | Buy → Neutral | Get Alert | |
| 02/26/2020 | FATE | Buy Now | Fate Therapeutics | $1.10 | 3536.36% | $33 → $40 | Maintains | Buy | Get Alert | |
| 02/12/2020 | FTSV | Buy Now | Forty Seven | — | — | $37 → $53 | Maintains | Buy | Get Alert | |
| 01/03/2020 | INCY | Buy Now | Incyte | $99.08 | -20.27% | $98 → $79 | Downgrade | Buy → Neutral | Get Alert | |
| 12/30/2019 | FATE | Buy Now | Fate Therapeutics | $1.10 | 2900% | $27 → $33 | Reiterates | → Buy | Get Alert | |
| 12/10/2019 | FTSV | Buy Now | Forty Seven | — | — | $18 → $37 | Reiterates | → Buy | Get Alert | |
| 10/03/2019 | INCY | Buy Now | Incyte | $99.08 | -4.12% | → $95 | Initiates | → Buy | Get Alert | |
| 09/12/2019 | FTSV | Buy Now | Forty Seven | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 09/12/2019 | CRVS | Buy Now | Corvus Pharma | $8.26 | -15.25% | → $7 | Initiates | → Buy | Get Alert | |
| 09/06/2019 | CYTK | Buy Now | Cytokinetics | $64.34 | -68.92% | $14 → $20 | Reiterates | → Overweight | Get Alert | |
| 07/08/2019 | ARRY | Buy Now | Array Technologies | $8.60 | 458.14% | $34 → $48 | Downgrade | Overweight → Neutral | Get Alert | |
| 06/13/2019 | FATE | Buy Now | Fate Therapeutics | $1.10 | 2354.55% | → $27 | Initiates | → Buy | Get Alert | |
| 06/13/2019 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | 288.35% | → $16 | Initiates | → Buy | Get Alert | |
| 06/03/2019 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | 458.25% | $21 → $23 | Reiterates | → Overweight | Get Alert | |
| 05/14/2019 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | — | — | Initiates | → Overweight | Get Alert | |
| 04/03/2019 | VSTM | Buy Now | Verastem | $9.43 | -46.98% | → $5 | Initiates | → Overweight | Get Alert | |
| 01/15/2019 | ARRY | Buy Now | Array Technologies | $8.60 | 248.84% | → $30 | Initiates | → Overweight | Get Alert | |
| 09/21/2018 | CYTK | Buy Now | Cytokinetics | $64.34 | -78.24% | → $14 | Initiates | → Overweight | Get Alert | |
| 06/25/2018 | ARRY | Buy Now | Array Technologies | $8.60 | 202.33% | $24 → $26 | Maintains | Overweight | Get Alert | |
| 04/17/2018 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | -88.93% | $9 → $3 | Maintains | Neutral | Get Alert | |
| 04/17/2018 | CLDX | Buy Now | Celldex Therapeutics | $27.09 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 03/13/2018 | ADXS | Buy Now | Advaxis | $0.05 | 9703.92% | $19 → $5 | Maintains | Overweight | Get Alert | |
| 11/22/2017 | CYTK | Buy Now | Cytokinetics | $64.34 | — | — | Downgrade | Overweight → Neutral | Get Alert | |
| 10/24/2017 | CTMX | Buy Now | CytomX Therapeutics | $4.12 | 749.51% | → $35 | Initiates | → Overweight | Get Alert | |
| 10/12/2017 | ARDX | Buy Now | Ardelyx | $6.12 | 128.76% | $12 → $14 | Maintains | Overweight | Get Alert | |
| 09/14/2017 | AGTC | Buy Now | Applied Genetic Tech | — | — | $15 → $9 | Maintains | Neutral | Get Alert | |
| 09/11/2017 | ARRY | Buy Now | Array Technologies | $8.60 | 74.42% | $13 → $15 | Maintains | Overweight | Get Alert | |
| 09/06/2017 | VSTM | Buy Now | Verastem | $9.43 | — | — | Upgrade | Neutral → Overweight | Get Alert | |
| 07/12/2017 | PGNX | Buy Now | Progenics Pharmaceuticals | — | — | → $15 | Initiates | → Overweight | Get Alert | |
| 04/18/2017 | OMED | Buy Now | OptMed, Inc. | — | — | $16 → $6 | Downgrade | Buy → Neutral | Get Alert | |
| 04/18/2016 | OMED | Buy Now | OptMed, Inc. | — | — | → $16 | Initiates | → Buy | Get Alert | |
| 05/30/2014 | ARRY | Buy Now | Array Technologies | $8.60 | 4.65% | → $9 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved